Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My case for MO MONEY, a novelette

If he can determine the sentiment of retail shareholders is $1.00 that's what we'll get. If he determines it may be .50, that's what we'll get. The longs here need to stand firm about the value of our company. I say it is worth(based on what we know now) to be at a minimum of $1.50. Nothing should be done by the BOD or shareholders until we learn more from USTPO.

At .30 per share he may offer three times current share price if he thinks he can get away with it. Not enough Mr. Leckrone, not enough.

Keep your spirits up.

Share
New Message
Please login to post a reply